These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 7071843)

  • 1. The effect of ursodeoxycholic acid on biliary bile acid composition in patients with cholesterol gallstone.
    Kanazawa Y; Koizumi M; Hirakawa H; Endo K; Yoshida S; Miyakawa T; Konno Y; Goto Y; Goto J; Nambara T
    Tohoku J Exp Med; 1982 Mar; 136(3):235-49. PubMed ID: 7071843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of response to ursodeoxycholic acid for gallstone dissolution.
    Bateson MC; Hill A; Bouchier IA
    Digestion; 1980; 20(5):358-64. PubMed ID: 7390061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
    Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
    Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
    Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
    J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
    Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
    Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
    [No Abstract]   [Full Text] [Related]  

  • 8. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
    Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
    Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of biliary cholesterol, phospholipids and bile acid compositions and the development of cholesterol cholelithiasis in mice].
    Yamahara J; Chisaka T; Sawada T; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):171-80. PubMed ID: 6662416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid in the Ursidae: biliary bile acids of bears, pandas, and related carnivores.
    Hagey LR; Crombie DL; Espinosa E; Carey MC; Igimi H; Hofmann AF
    J Lipid Res; 1993 Nov; 34(11):1911-7. PubMed ID: 8263415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholesterol gallstone dissolution in bile. Dissolution kinetics of crystalline cholesterol monohydrate by conjugated chenodeoxycholate-lecithin and conjugated ursodeoxycholate-lecithin mixtures: dissimilar phase equilibria and dissolution mechanisms.
    Salvioli G; Igimi H; Carey MC
    J Lipid Res; 1983 Jun; 24(6):701-20. PubMed ID: 6886562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of bile acids in bile with reversed-phase high-performance liquid chromatography.
    Nakayama F; Nakagaki M
    J Chromatogr; 1980 Sep; 183(3):287-93. PubMed ID: 7419646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the 3 alpha-hydroxysteroid dehydrogenase assay for ursodeoxycholic acid, and 7 oxo- and 12 oxo- bile acids.
    Haeffner LJ; Gordon SJ; Magen JS; Kowlessar OD
    J Lipid Res; 1980 May; 21(4):477-80. PubMed ID: 6929859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of bile acid synthesis. I. Effects of conjugated ursodeoxycholate and cholate on bile acid synthesis in chronic bile fistula rat.
    Heuman DM; Hernandez CR; Hylemon PB; Kubaska WM; Hartman C; Vlahcevic ZR
    Hepatology; 1988; 8(2):358-65. PubMed ID: 3356417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high and low doses of ursodeoxycholic acid on gallstone dissolution in humans.
    Salen G; Colalillo A; Verga D; Bagan E; Tint GS; Shefer S
    Gastroenterology; 1980 Jun; 78(6):1412-8. PubMed ID: 7372061
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermodynamic and molecular basis for dissimilar cholesterol-solubilizing capacities by micellar solutions of bile salts: cases of sodium chenodeoxycholate and sodium ursodeoxycholate and their glycine and taurine conjugates.
    Carey MC; Montet JC; Phillips MC; Armstrong MJ; Mazer NA
    Biochemistry; 1981 Jun; 20(12):3637-48. PubMed ID: 7260061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.